181 related articles for article (PubMed ID: 12427482)
1. Quercetin significantly decreased cyclosporin oral bioavailability in pigs and rats.
Hsiu SL; Hou YC; Wang YH; Tsao CW; Su SF; Chao PD
Life Sci; 2002 Dec; 72(3):227-35. PubMed ID: 12427482
[TBL] [Abstract][Full Text] [Related]
2. Marked decrease of cyclosporin bioavailability caused by coadministration of ginkgo and onion in rats.
Yang CY; Chao PD; Hou YC; Tsai SY; Wen KC; Hsiu SL
Food Chem Toxicol; 2006 Sep; 44(9):1572-8. PubMed ID: 16762474
[TBL] [Abstract][Full Text] [Related]
3. Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin.
Choi JS; Piao YJ; Kang KW
Arch Pharm Res; 2011 Apr; 34(4):607-13. PubMed ID: 21544726
[TBL] [Abstract][Full Text] [Related]
4. Quercetin and rutin reduced the bioavailability of cyclosporine from Neoral, an immunosuppressant, through activating P-glycoprotein and CYP 3A4.
Yu CP; Wu PP; Hou YC; Lin SP; Tsai SY; Chen CT; Chao PD
J Agric Food Chem; 2011 May; 59(9):4644-8. PubMed ID: 21466223
[TBL] [Abstract][Full Text] [Related]
5. Lethal quercetin-digoxin interaction in pigs.
Wang YH; Chao PD; Hsiu SL; Wen KC; Hou YC
Life Sci; 2004 Jan; 74(10):1191-7. PubMed ID: 14697403
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.
Hendrikx JJ; Lagas JS; Rosing H; Schellens JH; Beijnen JH; Schinkel AH
Int J Cancer; 2013 May; 132(10):2439-47. PubMed ID: 23090875
[TBL] [Abstract][Full Text] [Related]
7. 6',7'-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein.
Edwards DJ; Fitzsimmons ME; Schuetz EG; Yasuda K; Ducharme MP; Warbasse LH; Woster PM; Schuetz JD; Watkins P
Clin Pharmacol Ther; 1999 Mar; 65(3):237-44. PubMed ID: 10096255
[TBL] [Abstract][Full Text] [Related]
8. Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats.
Shin SC; Choi JS; Li X
Int J Pharm; 2006 Apr; 313(1-2):144-9. PubMed ID: 16516418
[TBL] [Abstract][Full Text] [Related]
9. Baicalin reduces ciclosporin bioavailability by inducing intestinal p-glycoprotein in rats.
Tian X; Chang Y; Wei J; Liu R; Wang L; Zhang J; Zhang X
J Pharm Pharmacol; 2019 May; 71(5):788-796. PubMed ID: 30663770
[TBL] [Abstract][Full Text] [Related]
10. Relative bioavailability of Neoral versus Sandimmune in the presence of a P450IIIA and P-glycoprotein inhibitor.
Choc MG; Mueller EA; Robinson WT; Kumle A; Smith HT; Charnick SB
Transplant Proc; 1998 Aug; 30(5):1664-5. PubMed ID: 9723234
[No Abstract] [Full Text] [Related]
11. Pharmacokinetic role of P-glycoprotein in oral bioavailability and intestinal secretion of grepafloxacin in vivo.
Yamaguchi H; Yano I; Saito H; Inui K
J Pharmacol Exp Ther; 2002 Mar; 300(3):1063-9. PubMed ID: 11861816
[TBL] [Abstract][Full Text] [Related]
12. Effects of myricetin on the bioavailability of doxorubicin for oral drug delivery in rats: possible role of CYP3A4 and P-glycoprotein inhibition by myricetin.
Choi SJ; Shin SC; Choi JS
Arch Pharm Res; 2011 Feb; 34(2):309-15. PubMed ID: 21380815
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of factors to decrease bioavailability of cyclosporin A in rats with gentamicin-induced acute renal failure.
Shibata N; Inoue Y; Fukumoto K; Nishimura A; Fukushima K; Yoshikawa Y; Spiteller G; Takada K
Biol Pharm Bull; 2004 Mar; 27(3):384-91. PubMed ID: 14993807
[TBL] [Abstract][Full Text] [Related]
14. Grapefruit juice effects on the bioavailability of cyclosporin-A in rats.
Mangano NG; Cutuli VM; Caruso A; De Bernardis E; Amico-Roxas M
Eur Rev Med Pharmacol Sci; 2001; 5(1):1-6. PubMed ID: 11860217
[TBL] [Abstract][Full Text] [Related]
15. Effects of roxithromycin on the pharmacokinetics of loratadine after oral and intravenous administration of loratadine in rats.
Li C; Kim CS; Yang JY; Park YJ; Choi JS
Eur J Drug Metab Pharmacokinet; 2008; 33(4):231-6. PubMed ID: 19230596
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic interaction between diltiazem and morin, a flavonoid, in rats.
Choi JS; Han HK
Pharmacol Res; 2005 Nov; 52(5):386-91. PubMed ID: 16002304
[TBL] [Abstract][Full Text] [Related]
17. Effects of efonidipine on the pharmacokinetics and pharmacodynamics of repaglinide: possible role of CYP3A4 and P-glycoprotein inhibition by efonidipine.
Li C; Choi DH; Choi JS
J Pharmacokinet Pharmacodyn; 2012 Feb; 39(1):99-108. PubMed ID: 22210483
[TBL] [Abstract][Full Text] [Related]
18. In vivo effects of cyclosporin A and ketoconazole on the pharmacokinetics of representative substrates for P-glycoprotein and cytochrome P450 (CYP) 3A in rats.
Kageyama M; Namiki H; Fukushima H; Ito Y; Shibata N; Takada K
Biol Pharm Bull; 2005 Feb; 28(2):316-22. PubMed ID: 15684491
[TBL] [Abstract][Full Text] [Related]
19. Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5.
Mouly SJ; Matheny C; Paine MF; Smith G; Lamba J; Lamba V; Pusek SN; Schuetz EG; Stewart PW; Watkins PB
Clin Pharmacol Ther; 2005 Dec; 78(6):605-18. PubMed ID: 16338276
[TBL] [Abstract][Full Text] [Related]
20. Modulation of mdr1a and CYP3A gene expression in the intestine and liver as possible cause of changes in the cyclosporin A disposition kinetics by dexamethasone.
Yokogawa K; Shimada T; Higashi Y; Itoh Y; Masue T; Ishizaki J; Asahi M; Miyamoto K
Biochem Pharmacol; 2002 Feb; 63(4):777-83. PubMed ID: 11992648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
